Search Results for: Marc Tessier-Lavigne
The annual recipient of the NY/NJ CEO Lifetime Achievement Award is nominated and elected by peers from within the biotechnology industry and it recognizes the extraordinary contributions of the awardees toward advancing medical science and products that address unmet medical needs, as well as in helping to create an environment that fosters the growth of the industry in the New York metropolitan area.
Congress of the United States U.S. House of Representatives Committee on Science, Space, and Technology Subcommittee on Research and Technology “Policies to Spur Innovative Medical Breakthroughs from Laboratories to Patients” Written Testimony of Dr. Marc Tessier-Lavigne Rayburn House Office Building … More »
Medical innovation requires federal support and structural improvements, Marc Tessier-Lavigne tells members of Congress
Speaking at a hearing on public versus private contributions to medical breakthroughs, Rockefeller’s president explained the ecosystem responsible for taking a biological insight on, for example, how tumors spread, and turning it into a treatment that improves or saves lives. He also offered suggestions for how the federal government could further encourage such breakthroughs.
Tessier-Lavigne, Rockefeller president and head of the Laboratory of Brain Development, and Jeffrey M. Friedman head of the Laboratory of Molecular Genetics, were elected to the honorary society and independent policy research center along with 198 other leaders in science, art, academia and the civic, corporate and philanthropic arenas. The current membership includes some 250 Nobel laureates and more than 60 Pulitzer Prize winners, and 23 other Rockefeller University faculty members are fellows.
President Marc Tessier-Lavigne will receive the Henry G. Friesen International Prize in Health Research, established by the Friends of Canadian Institutes of Health Research in collaboration with the Canadian Academy of Health Sciences to recognize exceptional innovation by a visionary health leader of international stature.
A world leader in the study of brain development, Tessier-Lavigne has pioneered the identification of the molecules that direct the formation of connections among nerve cells to establish neuronal circuits in the mammalian brain and spinal cord. Tessier-Lavigne is among 65 new members and five foreign associates elected to the Institute this year. More »
Rockefeller University’s President will receive the Memorial Sloan-Kettering Medal for Outstanding Contributions to Biomedical Research at MSKCC’s 2011 Academic Convocation. More »
Marc Tessier-Lavigne, a leading neuroscientist and the former chief scientific officer of Genentech, takes over as president of The Rockefeller University today, replacing Paul Nurse, who has left to become president of the Royal Society in London. More »
The university’s Board of Trustees has elected Tessier-Lavigne to succeed Paul Nurse on March 11, 2011. A leader in the study of brain development, he is currently executive vice president for research and chief scientific officer at Genentech, one the world’s leading biotech companies. More »
Genentech Brain Trust Leaves With $217 Million For New Startup To Fight Alzheimer’s And Parkinson’s “Three former top researchers at Genentech, the legendary biotech that is now part of Roche Holding, have raised $217 million in venture capital to … More »
The award recognizes Fuchs’s contributions to our understanding of skin biology and skin stem cells, including discoveries that have led to advancements in treating skin cancer and severe burns.
The Kavli Foundation and The Rockefeller University today announced the formation of the Kavli Neural Systems Institute (Kavli NSI) at Rockefeller, funded by a $20 million endowment supported equally by Kavli and Rockefeller. The Institute will become part of a network of seven Kavli Institutes carrying out fundamental research in neuroscience, and a broader network of 20 Kavli Institutes dedicated to astrophysics, nanoscience, neuroscience, and theoretical physics. More »
Shixin Liu, a biophysicist and Rockefeller’s newest tenure-track faculty member, investigates how these individual machines within the cell interact, and, in many cases, cooperate to accomplish critical tasks, such as DNA transcription and gene regulation. Liu will establish the Laboratory of Nanoscale Biophysics and Biochemistry as of January 1. More »
Thomas Walz, a structural biologist, will establish the Laboratory of Molecular Electron Microscopy as of September 1. Walz uses cutting edge tools in electron microscopy to examine macromolecular complexes and proteins embedded in cellular membranes, and he will help biologists from other fields use the same techniques for their research. More »
Six young scientists at Memorial Sloan Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College have been named the inaugural winners of a new prize for postdoctoral investigators in the life sciences. The Breakout Awards were established by three Tri-Institutional winners of the 2013 Breakthrough Prize in Life Science with additional financial support from the institutions themselves. More »
Marraffini, who studies the CRISPR-Cas systems that enable some bacteria to acquire immunity against viruses, is among 32 highly qualified young faculty researchers selected to compete for this national award. More »